Katie Ellias
Director/Board Member at SAB BIOTHERAPEUTICS, INC.
Profile
Katie Ellias joined the T1D Fund in July 2018 as a Managing Director from Endeavour Vision, a Geneva-based growth stage venture fund, where she focused on medical devices and digital health as Senior Investment Director.
She was previously Principal at Sofinnova Partners, Paris, a leading early stage life sciences fund, investing in medical technologies.
She served as Board Observer for ReCor Medical (sold to Otsuka Holdings), CorWave, Shockwave Medical (NASDAQ: SWAV), RefleXion Medical, Pixium Vision (PIX.PA), and MD Start, a medical device accelerator.
Prior to VC, Katie held roles in Business Development, Sales and Marketing at Medtronic in the Cardiac and Vascular businesses.
She began her career at McKinsey & Company and Partners Healthcare in Boston.
Katie holds a M.B.A.
in Healthcare Management from the Wharton School at the University of Pennsylvania and a B.A.
cum laude in International Relations and Political Science from Yale University.
Katie Ellias active positions
| Companies | Position | Start |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Director/Board Member | 19/11/2023 |
JDRF T1D Fund
 JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 30/06/2018 |
Former positions of Katie Ellias
| Companies | Position | End |
|---|---|---|
Capillary Biomedical LLC
 Capillary Biomedical LLC Medical SpecialtiesHealth Technology Capillary Biomedical, Inc. develops medical devices for diabetes management. The company was founded by Jeffrey Joseph and Paul Strasma and is headquartered in Irvine, CA. | Director/Board Member | 30/06/2022 |
Tech Health Experts
 Tech Health Experts Information Technology ServicesTechnology Services Tech Health Experts provides technical support services. | Consultant / Advisor | 29/07/2018 |
Endeavour Vision SA
 Endeavour Vision SA Investment ManagersFinance Endeavour Vision SA (EV) is an independent venture capital firm headquartered in Geneva. EV traces their origins back to 1989 through the convergence of the Vision Capital European team and the Swiss VC firm, Endeavour. EV was co-founded in 2000 by Sven Lingjaerde and Damien Tappy. The firm specializes in providing funding for entrepreneurs in life sciences, biotech, medtech, cleantech and information technology. EV operates in close cooperation with Genevest, an independent investment vehicle which has reached the divestment stage. Their investors in the funds they advise are industrial corporations, family offices, global institutional investors and business leaders in the technology and investment industry. | Private Equity Investor | 29/09/2017 |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Private Equity Investor | 29/11/2016 |
DiogenX SAS
 DiogenX SAS BiotechnologyHealth Technology DiogenX SAS engages in the discovery and development of biologics therapeutics options of Diabetic patients. It operates in Diabetes preclinical stage business segment. The company was founded by Benjamin Charles, Patrick Collombat and Jean Pascal Tranié on December 24, 2019 and is headquartered in Marseille, France. | Director/Board Member | - |
Training of Katie Ellias
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Yale University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SAB BIOTHERAPEUTICS, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Veralox Therapeutics, Inc.
 Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Health Technology |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Finance |
I2o Therapeutics, Inc.
 I2o Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology I2o Therapeutics, Inc. develops injection pills for biological therapies. It offers revolutionary oral delivery platform such as high bioavailability, low cost of goods, superior drug loading, injection free delivery, readily scalable, and compatible with diverse drug types. The company was founded by Samir Mitragotri, Ravi Srinivasan, Kelly Ibsen, and Tyler Brown in 2019 and is headquartered in Allston, MA. | Health Technology |
Capillary Biomedical LLC
Capillary Biomedical LLC Medical SpecialtiesHealth Technology Capillary Biomedical, Inc. develops medical devices for diabetes management. The company was founded by Jeffrey Joseph and Paul Strasma and is headquartered in Irvine, CA. | Health Technology |
DiogenX SAS
DiogenX SAS BiotechnologyHealth Technology DiogenX SAS engages in the discovery and development of biologics therapeutics options of Diabetic patients. It operates in Diabetes preclinical stage business segment. The company was founded by Benjamin Charles, Patrick Collombat and Jean Pascal Tranié on December 24, 2019 and is headquartered in Marseille, France. | Health Technology |
Tech Health Experts
Tech Health Experts Information Technology ServicesTechnology Services Tech Health Experts provides technical support services. | Technology Services |
Endeavour Vision SA
Endeavour Vision SA Investment ManagersFinance Endeavour Vision SA (EV) is an independent venture capital firm headquartered in Geneva. EV traces their origins back to 1989 through the convergence of the Vision Capital European team and the Swiss VC firm, Endeavour. EV was co-founded in 2000 by Sven Lingjaerde and Damien Tappy. The firm specializes in providing funding for entrepreneurs in life sciences, biotech, medtech, cleantech and information technology. EV operates in close cooperation with Genevest, an independent investment vehicle which has reached the divestment stage. Their investors in the funds they advise are industrial corporations, family offices, global institutional investors and business leaders in the technology and investment industry. | Finance |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Finance |
- Stock Market
- Insiders
- Katie Ellias
